Bodo Levkau

12.7k total citations · 2 hit papers
157 papers, 9.2k citations indexed

About

Bodo Levkau is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Bodo Levkau has authored 157 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 41 papers in Cardiology and Cardiovascular Medicine and 34 papers in Surgery. Recurrent topics in Bodo Levkau's work include Sphingolipid Metabolism and Signaling (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Lipid Membrane Structure and Behavior (14 papers). Bodo Levkau is often cited by papers focused on Sphingolipid Metabolism and Signaling (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (17 papers) and Lipid Membrane Structure and Behavior (14 papers). Bodo Levkau collaborates with scholars based in Germany, United States and Japan. Bodo Levkau's co-authors include Elaine W. Raines, Russell Ross, Petra Keul, Gerd Assmann, Michael Schäfers, Gerd Heusch, Manfred Fobker, Jerzy–Roch Nofer, Barbara Herren and Karin von Wnuck Lipinski and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Bodo Levkau

155 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

2004 538 citations Karin von Wnuck Lipinski, Hideo A. Baba et al. profile →
HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3

2004 510 citations Jerzy–Roch Nofer, Karin von Wnuck Lipinski et al. profile →

Peers

Countries citing papers authored by Bodo Levkau

Since Specialization

Citations

This map shows the geographic impact of Bodo Levkau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bodo Levkau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bodo Levkau more than expected).

Fields of papers citing papers by Bodo Levkau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bodo Levkau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bodo Levkau. The network helps show where Bodo Levkau may publish in the future.

Co-authorship network of co-authors of Bodo Levkau

This figure shows the co-authorship network connecting the top 25 collaborators of Bodo Levkau. A scholar is included among the top collaborators of Bodo Levkau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bodo Levkau. Bodo Levkau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A secretome atlas of cardiac fibroblasts from healthy and infarcted mouse hearts 2025 ·Communications Biology ·(unknown), Gereon Poschmann, (unknown), Martin Busch, Zhaoping Ding, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Tobias Lautwein, Christina Alter, Junedh Amrute, Kory J. Lavine, Karl Köhrer, Bodo Levkau, Patrick Most, Kai Stühler, Julia Hesse, Jürgen Schrader	1
2	Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets 2025 ·Cardiovascular Research ·Roland Klingenberg, Andreas Leiherer, Dobromir Dobrev, Juan Carlos Kaski, Bodo Levkau, Winfried März, Samuel Sossalla, Arnold von Eckardstein, Heinz Drexel	2
3	Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies 2024 ·Experimental Cell Research ·Melanie Müller, (unknown), Margaretha A. Skowron, (unknown), (unknown), (unknown), Patrick Petzsch, Leandro A. Alves Avelar, Thomas Kurz, Karl Köhrer, Bodo Levkau, Daniel Nettersheim	1
4	Identification of myeloid-derived growth factor as a mechanically-induced, growth-promoting angiocrine signal for human hepatocytes 2024 ·Nature Communications ·(unknown), (unknown), Kristina Behnke, (unknown), (unknown), Philip Kirschner, Sonja Hartwig, Stefan Lehr, Mortimer Korf‐Klingebiel, Daniel Eberhard, Nadja Lehwald, Hadi Al‐Hasani, Wolfram Trudo Knoefel, Stefan Heinrich, Bodo Levkau, Kai C. Wollert, Jürgen Scheller, Eckhard Lammert	7
5	The fate of intracellular S1P regulates lipid droplet turnover and lipotoxicity in pancreatic beta-cells 2024 ·Journal of Lipid Research ·(unknown), (unknown), (unknown), Ilir Mehmeti, (unknown), (unknown), Bodo Levkau, Julie D. Saba, Gerhild van Echten‐Deckert, Ewa Gurgul-Convey	4
6	Synthesis, radiosynthesis and biochemical evaluation of fluorinated analogues of sphingosine-1-phosphate receptor 3 specific antagonists using PET 2024 ·Bioorganic & Medicinal Chemistry ·(unknown), Stefan Wagner, Petra Keul, Sven Hermann, Bodo Levkau, Michael Schäfers, Günter Haufe	1
7	SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction 2023 ·BMC Cardiovascular Disorders ·Florian Bönner, Christian Jung, Amin Polzin, Ralf Erkens, Lisa Dannenberg, (unknown), (unknown), (unknown), (unknown), Oana‐Patricia Zaharia, Christian Meyer, Ulrich Flögel, Bodo Levkau, Axel Gödecke, Jens W. Fischer, (unknown), Martina Krüger, Michael Roden, Malte Kelm	2
8	Sphingosine-1-phosphate suppresses GLUT activity through PP2A and counteracts hyperglycemia in diabetic red blood cells 2023 ·Nature Communications ·(unknown), (unknown), (unknown), (unknown), Shahrooz Ghaderi, Karin von Wnuck Lipinski, (unknown), (unknown), (unknown), Markus H. Gräler, Lisa Dannenberg, (unknown), Philipp Westhoff, Amin Polzin, Malte Kelm, Petra Keul, Sarah Weske, Bodo Levkau	9
9	Pharmacological elevation of sphingosine‐1‐phosphate by S1P lyase inhibition accelerates bone regeneration after post‐traumatic osteomyelitis 2023 ·Journal of Cellular and Molecular Medicine ·Johannes Maximilian Wagner, (unknown), (unknown), Sarah Weske, Sebastian Lotzien, (unknown), Christoph Wallner, Alexander Sogorski, (unknown), Mustafa Becerikli, Thomas A. Schildhauer, Marcus Lehnhardt, Bodo Levkau, Björn Behr	3
10	The mycotoxin viriditoxin induces leukemia- and lymphoma-specific apoptosis by targeting mitochondrial metabolism 2022 ·Cell Death and Disease ·Fabian Stuhldreier, (unknown), Thomas Lenz, (unknown), Marcel Zimmermann, (unknown), (unknown), Yang Liu, Paul F. Jäger, Stefanie Geyh, Nicole Teusch, Christoph Peter, Sanil Bhatia, Rainer Haas, Bodo Levkau, Andreas S. Reichert, Kai Stühler, Peter Proksch, Björn Stork, Sebastian Wesselborg	7
11	S1P Lyase Inhibition Starting After Ischemia/Reperfusion Improves Postischemic Cardiac Remodeling 2022 ·JACC Basic to Translational Science ·Amin Polzin, Lisa Dannenberg, (unknown), (unknown), Petra Keul, Carolin Helten, Tobias Zeus, Malte Kelm, Bodo Levkau	3
12	Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus 2021 ·Diabetologia ·(unknown), Stephen Gerfer, (unknown), Sören Twarock, Sonja Hartwig, Stefan Lehr, (unknown), (unknown), Carolin Helten, Petra Keul, S. Kahl, Amin Polzin, Margitta Elvers, Ulrich Flögel, Malte Kelm, Bodo Levkau, Michael Roden, Jens W. Fischer, Maria Grandoch	33
13	Prednisone prevents particle induced bone loss in the calvaria mouse model 2021 ·Heliyon ·Michael M. Schündeln, (unknown), (unknown), (unknown), Max Daniel Kauther, Gero Hilken, Bodo Levkau, Martina Rauner, Corinna Grasemann	2
14	Platelet reactivity in patients with chronic kidney disease and hemodialysis 2019 ·Journal of Thrombosis and Thrombolysis ·Philipp Mourikis, Carolin Helten, Lisa Dannenberg, Thomas Hohlfeld, Johannes Stegbauer, Tobias Petzold, Bodo Levkau, Tobias Zeus, Malte Kelm, Amin Polzin	7
15	Thromboxane Formation Assay to Identify High On-Treatment Platelet Reactivity to Aspirin 2017 ·Pharmacology ·(unknown), Kerstin Piayda, Lisa Dannenberg, (unknown), Theresa Schneider, (unknown), Bodo Levkau, Tobias Zeus, Malte Kelm, Thomas Hohlfeld, Amin Polzin	6
16	Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin 2015 ·Nature Communications ·Claudia Nußbaum, (unknown), Petra Keul, Markus H. Gräler, Cassiano Felippe Gonçalves-de-Albuquerque, Hanna Korhonen, Karin von Wnuck Lipinski, Gerd Heusch, Hugo Caire de Castro Faria Neto, Ina Rohwedder, Joachim R. Göthert, (unknown), Günter Haufe, Baerbel Lange‐Sperandio, Stefan Offermanns, Markus Sperandio, Bodo Levkau	74
17	The coronary circulation in cardioprotection: more than just one confounder 2011 ·Cardiovascular Research ·Gerd Heusch, Petra Kleinbongard, Andreas Skyschally, Bodo Levkau, Rainer Schulz, Raimund Erbel	64
18	Lack of Myoglobin Causes a Switch in Cardiac Substrate Selection 2005 ·Circulation Research ·Ulrich Flögel, Tim Laußmann, Axel Gödecke, (unknown), Michael Schäfers, Christian D. Fingas, Sabine Metzger, Bodo Levkau, Christoph Jacoby, Jürgen Schrader	54
19	Myokardiale Veränderungen unter mechanischer linksventrikulärer Unterstützungstherapie 2003 ·Der Pathologe ·Florian Grabellus, Christopher H. Schmid, Bodo Levkau, J. Stypmann, H. H. Scheld, Hideo A. Baba	4
20	Involvement of Cdc42 Signaling in ApoA-I-induced Cholesterol Efflux 2003 ·Journal of Biological Chemistry ·Jerzy–Roch Nofer, (unknown), Bodo Levkau, (unknown), Udo Seedorf, Gerd Assmann	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact